Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Kerr

Showing results (21-30 of 218) with videos related to

Pageof 22
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2008
Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trialRebecca Pellicano, Kevan R Polkinghorne, Peter G Kerr
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 11, 2006
Anti-CD20 antibody treatment in refractory Class IV lupus nephritisRobert P Carroll, Fiona Brown, Peter G Kerr
Kidney360|April 4, 2022
Response to COVID-19 Infection in Hemodialysis Patients: An Australian PerspectiveKevan R Polkinghorne, Peter G Kerr, Neil Boudville
Kidney International. Supplement|March 9, 2005
What have we learned from clinical trials on prevention?Rebecca Pellicano, Peter G Kerr, Robert C Atkins
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 10, 2010
The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF maxAlain Ficheux, Peter G Kerr, Philippe Brunet, et al.
Nephrology (Carlton, Vic.)|September 16, 2015
How much is enough? An investigation of the relationship between haemodialysis adequacy and quality of life of elderly patientsEdward Zimbudzi, Reggie Samlero, Peter G Kerr, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 7, 2008
Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissueNigel D Toussaint, Grahame J Elder, Peter G Kerr
Kidney International|July 30, 2017
The fragility of significant results underscores the need of larger randomized controlled trials in nephrologyLani R Shochet, Peter G Kerr, Kevan R Polkinghorne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2020
Home and facility haemodialysis patients: a comparison of outcomes in a matched cohortEmily K Yeung, Kevan R Polkinghorne, Peter G Kerr
The Medical Journal of Australia|February 4, 2014
A pilot study of an influenza vaccination or mask mandate in an Australian tertiary health serviceRhonda L Stuart, Elizabeth E Gillespie, Peter G Kerr
Pageof 22

Showing results (21-30 of 218) with videos related to

Sort By:
Pageof 22
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2008
Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trialRebecca Pellicano, Kevan R Polkinghorne, Peter G Kerr
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 11, 2006
Anti-CD20 antibody treatment in refractory Class IV lupus nephritisRobert P Carroll, Fiona Brown, Peter G Kerr
Kidney360|April 4, 2022
Response to COVID-19 Infection in Hemodialysis Patients: An Australian PerspectiveKevan R Polkinghorne, Peter G Kerr, Neil Boudville
Kidney International. Supplement|March 9, 2005
What have we learned from clinical trials on prevention?Rebecca Pellicano, Peter G Kerr, Robert C Atkins
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 10, 2010
The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF maxAlain Ficheux, Peter G Kerr, Philippe Brunet, et al.
Nephrology (Carlton, Vic.)|September 16, 2015
How much is enough? An investigation of the relationship between haemodialysis adequacy and quality of life of elderly patientsEdward Zimbudzi, Reggie Samlero, Peter G Kerr, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 7, 2008
Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissueNigel D Toussaint, Grahame J Elder, Peter G Kerr
Kidney International|July 30, 2017
The fragility of significant results underscores the need of larger randomized controlled trials in nephrologyLani R Shochet, Peter G Kerr, Kevan R Polkinghorne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2020
Home and facility haemodialysis patients: a comparison of outcomes in a matched cohortEmily K Yeung, Kevan R Polkinghorne, Peter G Kerr
The Medical Journal of Australia|February 4, 2014
A pilot study of an influenza vaccination or mask mandate in an Australian tertiary health serviceRhonda L Stuart, Elizabeth E Gillespie, Peter G Kerr
Pageof 22